Tag: vaccine
La Trobe University to house BioNTech’s new mRNA manufacturing facility
La Trobe University’s Melbourne campus will soon become home to a new BioNTech facility that will manufacture new investigational mRNA therapies for serious diseases like cancer.
University of Adelaide projects win grants to foster research partnerships
Researchers from the University of Adelaide have received federal grants that will support two projects that will help develop a vaccine to protect poultry against salmonella and identify important plant compounds.
National team of experts developing technology to boost Australia’s vaccine manufacturing capability
A team of scientific experts are developing a biopolymer particle-based platform technology that will bring Australia a step closer towards establishing a sovereign capability to rapidly manufacture vaccines against emerging infectious diseases.
Vaxxas’ new needle-free vaccine manufacturing plant opens in Queensland
Biotechnology company Vaxxas has completed work on its new needle-free vaccine technology manufacturing facility in Northshore Hamilton.
Vaxxas unveils positive clinical trial results for needle-free COVID-19 vaccine
Australia biotechnology company Vaxxas said it achieved positive interim results from a Phase I human clinical trial with the first needle-free COVID-19 vaccine candidate.
CSL’s $800 million vaccine manufacturing facility in Melbourne nears completion
CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing.
WEHI-led research on anti-cancer vaccine receives $900,000 MRFF funding
Walter and Eliza Hall of Medical Research (WEHI) has received a $900,000 grant from the Medical Research Future Fund for a research study that could produce a vaccine for patients with hard-to-treat cancers.
Victoria backs Monash’s advanced mRNA vaccine manufacturing training centre
The Victorian government has announced a $10 million investment in the Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training.
Vaxxas’ needle-free seasonal influenza vaccine enters clinical trial
Vaxxas has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.
Queensland to open new $280m mRNA vaccine hub with Sanofi
The Queensland government has invested $280 million in a partnership with Sanofi to establish the Translational Science Hub, providing a boost for the next-generation mRNA vaccine research in the state.
Featured Article
Beyond insights: How CRM solutions are transforming the manufacturing industry
The global manufacturing sector is witnessing a seismic shift in its automation approach as companies worldwide, big or small, grapple with the ongoing labour shortage and skills gap within the industry.
